An India-made, low-cost, point of care (POC) test to detect certain life-threatening blood related genetic disorders ...

J.R. Landry became one of only a handful in the nation, and the first in Rhode Island, to get what doctors believe will be ...

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...

The results of gene therapy for hemophilia B contrast with those of factor replacement therapies, where lifelong infusions ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

This spontaneous mutation pattern explains why hemophilia A can appear unexpectedly in families with no known bleeding disorders. Genetic testing now allows precise identification of the specific ...

Learn how clotting factor therapy, gene therapy, and non-factor treatments are improving hemophilia prognosis and life expectancy.

Chandrapur (Maharashtra): An India-made, low-cost, point of care (POC) test to detect certain life-threatening blood related genetic disorders including Hemophilia that enables even rural ...

Let’s break down five genetic disorders that mostly affect men, what you should know about them, and how you can take action. Hemophilia is a well-known genetic disorder that mostly affects men.

China recently approved its first gene therapy for the rare genetic disorder hemophilia B, drawing renewed attention to this often-overlooked condition. Hemophilia is a rare but serious inherited ...

The study was published in Blood Advances. Hemophilia A is a genetic disorder that impairs the blood's ability to clot, caused by a deficiency in a clotting protein called factor VIII (FVIII).

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...